Healthcare and Life Science
London BioScience Innovation Centre welcomes Baseimmune Ltd to its new fully fitted grow-on lab space within the Apex Building, Tribeca
Baseimmune facilitates growth with move to the Apex Building, part of the Tribeca development - London’s latest grow-on lab space Latest sign-up increases LBIC’s pre-let occupancy at Apex to 35% LONDON, UK 19th August 2024: ...
Global spotlight on Cambridge heart trial
A landmark trial undertaken by Cambridge researchers, which may help prevent patients from having repeat heart attacks, will be presented at the largest cardiology conference globally. ...
Xampla’s nutrient microencapsulation technology brought to market with Lehmann Ingredients
Food manufacturing supplier, Lehmann Ingredients, becomes the first distributor partner to offer materials company Xampla’s nutrient microencapsulation technology. New partnership will enable FMCG brands and supply partners across the UK to deliver encapsulated nutrients for enteric...
Football match is most important in decades
An event billed as “the most important game of football since 1863” and supported by clinicians at Addenbrooke’s Hospital, will take place at Cambridge’s Parker’s Piece on Sunday, 1 September 2024. ...
Human endometrial map uncovers hidden health clues
The most comprehensive map of the human endometrium, the inner lining of the uterus, has been created, uncovering diverse cell types and detailing the dynamic changes these go through during the menstrual cycle. ...
Nxera Pharma notes positive topline results from its Phase 2 clinical study in adults with schizophrenia
Tokyo, Japan and Cambridge, UK - Nxera Pharma Co., Ltd. – formerly known as Sosei Group or Sosei Heptares – notes the announcement by its partner Neurocrine Biosciences Inc., that NBI-1117568 (NBI-‘568) has delivered positive topline results from its Phase 2 clinical study in adults wit...
Innovate Cambridge appoints Kathryn Chapman to lead mission to amplify world-leading innovation ecosystem
Kathryn Chapman, previously Innovation Director at Babraham Research Campus will build on the success of Tabitha Goldsmith to lead Innovate Cambridge, the body responsible for increasing the UK city’s innovation and tech impact, building on the success of Tabitha Goldstaub After a de...
Nxera Pharma to receive US$35 Million from Neurocrine Biosciences upon positive phase 2 data for partnered Schizophrenia candidate NBI-1117568
Tokyo, Japan and Cambridge, UK - Nxera Pharma Co., Ltd. - formerly known as Sosei Group or Sosei Heptares – announces it will receive a US$35 million payment from Neurocrine Biosciences, triggered by the successful completion of the Phase 2 trial with NBI-1117568 (NBI-‘568) in adults wi...
ARU vision research shortlisted for national awards
Anglia Ruskin University nominated in two categories by Times Higher Education.
Qkine expands senior leadership
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer. ...